人类肥胖及相关多系统疾病的多组学研究
这些蛋白多参与脂肪生成、炎症、糖代谢及神经食欲调节,部分具有减重药物再利用潜力。
要点
- 122种血浆蛋白与肥胖指标显著关联,121种在UK Biobank重复。
- 因果相关蛋白在脂肪和脑组织及脂肪细胞中转录丰度升高。
核心结论
- 分析揭示了既受肥胖影响又影响肥胖的关键调控机制,为生物标志物和临床干预提供了有价值的靶点。
研究设计与样本
- 利用共定位和孟德尔随机化评估显著蛋白与肥胖及肥胖相关疾病的共享基础及因果方向。
主要发现
- 122种蛋白与肥胖指标显著关联(FDR<0.05),其中121种在UKBB重复。
- 多数重复蛋白功能涉及脂肪生成、炎症、糖代谢及神经和食欲调节。
- 因果相关蛋白在脂肪和脑组织及脂肪细胞中转录丰度升高。
- 若干靶蛋白具有减重潜力,适合未来药物再利用。
临床怎么用
- 鉴定的蛋白可作为肥胖及相关疾病的潜在生物标志物。
- 部分靶蛋白具有减重药物开发或再利用的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Efforts to characterize the shared molecular risk factors that contribute to obesity and the downstream disease sequelae it triggers have been limited. OBJECTIVE: We aimed to identify functional genes with evidence for both causal and consequential effects on obesity-related traits and their downstream sequalae using integrated genomic and proteomic data. METHODS: We investigated the association of obesity-related traits with 2912 plasma proteins in 259 individuals from the Cameron County Hispanic Cohort with validation of results in ∼45 000 participants from the UK Biobank. Through colocalization and Mendelian randomization, we assessed evidence for the shared underpinning and the causal direction of significant proteins with respect to obesity and obesity-associated illnesses. We used gene ontology and cell- and tissue-specific protein and transcriptional activity patterns of the genes encoding target proteins to illuminate the functional relevance of implicated pathways. We additionally investigated the suitability of target proteins as potential therapeutic targets for drug development. RESULTS: Of the 122 significantly associated proteins with obesity metrics at a false discovery adjusted level (false discovery rate < 0.05), 121 replicated in UKBB. Most function in adipogenesis, inflammation, glucose metabolism, and neural and appetite regulation. Eighty of 121 replicated proteins showed evidence of statistical causality for obesity or obesity-associated illnesses. Those causally linked showed elevated transcript abundance in adipose and brain tissues and adipocytes. The promising weight reduction potential of several target proteins highlights their suitability for future pharmaceutical repurposing. CONCLUSION: Our analyses revealed key regulatory mechanisms influenced by and influencing obesity, offering valuable targets for biomarkers and clinical interventions.
引用
- Anwar MY, Highland HM, Sheng Q, et al. Multiomics of Human Obesity and Related Multisystem Diseases. J Clin Endocrinol Metab. 2026. PMID: 40581728. doi:10.1210/clinem/dgaf373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。